MAPT and Cognitive impairment: We focused on potential associations of the rs1746661 SNP with cognitive function, Aβ or tau pathology, as they are hallmarks of AD pathology and disease progression.45 No significant difference in the prevalence of cognitive impairment or AD was detected between carriers and non-carriers of rs1746661 MA.